SynthesisAnnals of hematology2026

Anti-CD3/CD20 bispecific antibodies as salvage therapy after CAR-T failure in relapsed/refractory large B-cell lymphoma: a systematic review and meta-analysis.

Ning Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.